Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Innovations in Clinical Neuroscience
|
May 4, 2018
Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder
Steven D Targum, Christopher Murphy, Jibran Khan, et al.
Annals of General Psychiatry
|
February 2, 2013
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials
Steven D Targum, Celine Houser, Joanne Northcutt, et al.
Schizophrenia Research
|
October 7, 2016
Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia
Steven D Targum, Robert Risinger, Yangchun Du, et al.
Frontiers in Psychiatry
|
August 4, 2025
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorder
Steven D Targum, Aksu Gunay, Alex Leow, et al.
Molecular Psychiatry
|
December 31, 2021
A novel peripheral biomarker for depression and antidepressant response
Steven D Targum, Jeffrey Schappi, Athanasia Koutsouris, et al.
Journal of Psychiatric Research
|
April 9, 2013
A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive Disorder
Steven D Targum, Pamela C Wedel, Jill Robinson, et al.
Schizophrenia Research
|
September 11, 2024
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials
William P Horan, Steven D Targum, Amy Claxton, et al.
Journal of Psychiatric Research
|
September 25, 2012
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery
Maurizio Fava, Steven D Targum, Andrew A Nierenberg, et al.
Journal of Clinical Psychopharmacology
|
March 19, 2026
Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression
Aristide Merola, Yuki Mukai, Tjerk Bueters, et al.
The Journal of Clinical Psychiatry
|
July 7, 2017
Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus Meeting
Phillip B Chappell, Michelle Stewart, Larry Alphs, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Innovations in Clinical Neuroscience
|
May 4, 2018
Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder
Steven D Targum, Christopher Murphy, Jibran Khan, et al.
Annals of General Psychiatry
|
February 2, 2013
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials
Steven D Targum, Celine Houser, Joanne Northcutt, et al.
Schizophrenia Research
|
October 7, 2016
Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia
Steven D Targum, Robert Risinger, Yangchun Du, et al.
Frontiers in Psychiatry
|
August 4, 2025
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorder
Steven D Targum, Aksu Gunay, Alex Leow, et al.
Molecular Psychiatry
|
December 31, 2021
A novel peripheral biomarker for depression and antidepressant response
Steven D Targum, Jeffrey Schappi, Athanasia Koutsouris, et al.
Journal of Psychiatric Research
|
April 9, 2013
A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive Disorder
Steven D Targum, Pamela C Wedel, Jill Robinson, et al.
Schizophrenia Research
|
September 11, 2024
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials
William P Horan, Steven D Targum, Amy Claxton, et al.
Journal of Psychiatric Research
|
September 25, 2012
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery
Maurizio Fava, Steven D Targum, Andrew A Nierenberg, et al.
Journal of Clinical Psychopharmacology
|
March 19, 2026
Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression
Aristide Merola, Yuki Mukai, Tjerk Bueters, et al.
The Journal of Clinical Psychiatry
|
July 7, 2017
Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus Meeting
Phillip B Chappell, Michelle Stewart, Larry Alphs, et al.
Page
of 8